Outset Medical

General Information


Outset is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. We believe Tablo represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings. We designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.

Our technology is designed to elevate the dialysis experience for patients, and help providers overcome traditional care delivery challenges. Our relentless focus on flexibility, ease of use and user experience translates to meaningfully reduced training times and fixed infrastructure requirements. 

Employees: 273
Founded: 2013
Contact Information
Address 3052 Orchard Drive, San Jose, CA 95134, US
Phone Number (669) 231-8200
Web Address http://www.outsetmedical.com
View Prospectus: Outset Medical
Financial Information
Market Cap $1105.65mil
Revenues $28.6 mil (last 12 months)
Net Income $-41.1 mil (last 12 months)
IPO Profile
Symbol OM
Exchange NASDAQ
Shares (millions): 9.0
Price range $27.00 - $27.00
Est. $ Volume $241.7 mil
Manager / Joint Managers BofA Securities/ Morgan Stanley/ Goldman Sachs
CO-Managers SVB Leerink/ Stifel
Expected To Trade: 9/15/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change